95
Participants
Start Date
August 15, 2022
Primary Completion Date
December 28, 2022
Study Completion Date
May 19, 2023
liquid chromatography-mass spectrometry (LC/MS)
Metabolomics is a rapidly evolving high-throughput technology that allows the measurement of the entire complement of metabolites generated by biochemical reactions under certain conditions in biological fluids or tissues. This technology has been used extensively to identify biomarkers in various cancers, nervous system diseases, cardiovascular diseases, pituitary diseases, and other diseases. The identification of biomarkers can be clinically useful for a more accurate diagnosis, prognosis, and treatment choice as well as disease monitoring. Among mass spectrometry (MS) methods, liquid chromatography- mass spectrometry (LC-MS) has been recognized as a robust metabolomics tool and has been widely applied in metabolite identification and quantification due to its high sensitivity, peak resolution, and reproducibility.
China Chongqing The third hospital affiliated to the Third Millitary Medical University, Chongqing
Third Military Medical University
OTHER